Purchases and Sales Made in Q1 2023 in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV) during Q1 2023. The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 01, 2023
Q1 2023
|
Compagnie Lombard Odier S Cm A
1204 Geneva, V8 |
BUY
|
- |
15K+ 30.0% |
$51.2K - $68.3K
|
65K
$71.5K
|
|
|
Apr 27, 2023
Q1 2023
|
Simplex Trading, LLC
|
BUY
|
- |
4.56K+ 55.93% |
$15.5K - $20.7K
|
12.7K
$14K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
500+ 0.92% |
$1.71K - $2.28K
|
54.7K
$60.2K
|
|
|
May 12, 2023
Q1 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
191+ 29.52% |
$651 - $869
|
838
$922
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-26- 26.53% |
$88.7 - $118
|
72
$79.2
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-38- 0.2% |
$130 - $173
|
18.9K
$20.8K
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-38- 0.2% |
$130 - $173
|
18.9K
$20.8K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-567- 1.39% |
$1.93K - $2.58K
|
40.2K
$44.2K
|
|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group Ltd.
Dublin, L2 |
SELL
|
- |
-1.02K- 5.41% |
$3.48K - $4.65K
|
17.9K
$19.7K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.05K- 8.94% |
$3.58K - $4.78K
|
10.7K
$11.8K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-1.99K- 5.96% |
$6.79K - $9.06K
|
31.5K
$34.6K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-10.1K- 16.91% |
$34.3K - $45.8K
|
49.5K
$54.4K
|